Âé¶¹Éç BioCapital
We are an evergreen venture capital fund that invests in life science companies, supporting the translation and commercialisation of ground-breaking science.
Our ambition
To identify scientific breakthroughs and develop new, ground-breaking medicines, and in the process generating an attractive financial return while supporting the growth of the Danish biotech ecosystem including by building long term sustainable businesses.
Investment Team
-
Senior Vice President, Managing Partner Âé¶¹Éç BioCapital
-
Operating Partner
-
Partner
-
Senior Principal
-
Principal
-
Associate
-
Associate
-
Executive Assistant & Facility Manager
News About Us
-
Âé¶¹Éç BioCapital
Âé¶¹Éç BioCapital and Heidrick & Struggles have concluded their ‘Fit for Future Growth’ pilot – a tailored programme aimed at helping early-stage biotech companies build value through increased awareness of the benefits, as well as the challenges, of working with diversity.
-
Âé¶¹Éç BioCapital
Danish biotech SNIPR Biome will use the EIB credit to develop new medicines for infections where existing antibiotics are no longer effective.
-
Âé¶¹Éç BioCapital
Danish start-up Kvantify secures EUR 10 million seed round to unlock quantum computing potential, starting with life sciences.
Where to meet us next
-
12May2025Âé¶¹Éç BioCapital
May 12-14
Bruges, Belgium
Celebrating its 25th year, Bio€quity Europe is the destination event for biopharma decision-makers to network, partner and debate critical issues facing the biotech industry.
